Developmental Research Grant Recipients
SARC awarded the following investigators and projects SARC Developmental Research Grants. A component of the SARC Sarcoma SPORE was funding for developmental research projects (2012–2016).
Funded Projects 2015–2016
DAVID KIRSCH, MD, PHD
YVONNE MOWERY, MD, PHD
Duke University Medical Center
Mechanisms that Regulate Sarcoma Response to Immune Checkpoint Inhibition of PD1
TSZ KWONG “CHRIS” MAN, PHD
Baylor College of Medicine
The Metastatic Role of Lysyl Oxidase in Osteosarcoma
WILLIAM W. TSENG, MD
University of Southern California
Immune Profiling in Well Differentiated/Dedifferentiated Liposarcoma
Funded Projects 2014–2015
LAURENCE BAKER, DO
University of Michigan
Can heart disease be predicted in young survivors of osteosarcoma using morphomics and/or coronary artery calcium scores?
DAVID KIRSCH, MD, PHD
YVONNE MOWERY, MD, PHD
Duke University Medical Center
Mechanisms that regulate sarcoma response to immune checkpoint Inhibition of PD1
SETH POLLACK, MD
Fred Hutchinson Cancer Research Center
Designing improved T-cell therapies for sarcoma patients
BRIAN RUBIN, MD, PHD
Cleveland Clinic Foundation
Identification of prognostic and therapeutic biomarkers in epithelioid hemangioendothelioma
ANAND SINGH, MD
Massaschusetts General Hospital
Computer-aided estimation of tumor viability fractions on MRI to facilitate procurement of negative surgical resection margins of musculoskeletal sarcoma
Funded Projects 2013–2014
ZHENFENG DUAN, PHD
Massachusetts General Hospital
Dissecting CDK11 kinase pathway in osteosarcoma
JONATHAN FLETCHER, MD
ADRIÁN MARIÑO-ENRIQUEZ, MD, PHD
Brigham & Women’s Hospital
Biomarkers for Dystrophin-deficiency in sarcoma
CHARLES KELLER, MD
Oregon Health & Science University
DAVID LANGENAU, PHD
Massachusetts General Hospital
GSK3-beta inhibitors for relapsed rhabdomyosarcom
DAVID KIRSCH, MD, PHD
REBECCA DODD, PHD
Duke University Medical Center
Translating discoveries from a mouse model into metastatic biomarker
STEPHEN LESSNICK, MD, PHD
SUNIL SHARMA, MD
University of Utah Huntsman Cancer Institute
Epigenetic targeting of LSD1 as a therapeutic strategy for Ewing sarcoma
BRIAN RUBIN, MD, PHD
Cleveland Clinic Foundation
Identification of prognostic and therapeutic biomarkers in epithelioid hemangioendothelioma
Funded Projects 2012–2013
ZHENFENG DUAN, PHD
Massachusetts General Hospital
Dissecting CDK11 kinase pathway in osteosarcoma
JONATHAN FLETCHER, MD
ADRIÁN MARIÑO-ENRIQUEZ, MD, PHD
Brigham & Women’s Hospital
Biomarkers for Dystrophin-deficiency in sarcoma
CHARLES KELLER, MD
Oregon Health & Science University
DAVID LANGENAU, PHD
Massachusetts General Hospital
GSK3-beta inhibitors for relapsed rhabdomyosarcoma
DAVID KIRSCH, MD, PHD
REBECCA DODD, PHD
Duke University Medical Center
Translating discoveries from a mouse model into metastatic biomarkers
STEPHEN LESSNICK, MD, PHD
SUNIL SHARMA, MD
University of Utah Huntsman Cancer Center
Epigenetic targeting of LSD1 as a therapeutic strategy for Ewing sarcoma
KEBIN LIU, PHD
Georgia Regents University
RAPHAEL POLLOCK, MD, PHD
Ohio State University
Combined radiosensitization and T cell immunotherapy for metastatic sarcoma